Related references
Note: Only part of the references are listed.Quantitative Analysis of Transthyretin, Tau and Amyloid-β in Patients with Dementia
Sara Friederike Gloeckner et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Use of Antidementia Drugs in Frontotemporal Lobar Degeneration
Secundino Lopez-Pousa et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2012)
Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice
Shabnam Ghazi-Noori et al.
BRAIN (2012)
Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics
Jennifer L. Whitwell et al.
BRAIN (2012)
FUS-related proteinopathies: Lessons from animal models
Nicholas A. Lanson et al.
BRAIN RESEARCH (2012)
Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a P301L tau knockin mouse
Jonathan Gilley et al.
NEUROBIOLOGY OF AGING (2012)
Genetics of Frontotemporal Lobar Degeneration
Daniela Galimberti et al.
Frontiers in Neurology (2012)
The APOE Gene Locus in Frontotemporal Dementia and Primary Progressive Aphasia
Davide Seripa et al.
ARCHIVES OF NEUROLOGY (2011)
Phenotypic signatures of genetic frontotemporal dementia
Jonathan D. Rohrer et al.
CURRENT OPINION IN NEUROLOGY (2011)
Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin Transcription RATIONAL THERAPEUTIC APPROACH TO FRONTOTEMPORAL DEMENTIA
Basar Cenik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Potential Mechanisms of Progranulin-deficient FTLD
Michael Emmerson Ward et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients
Paola Bossu et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
John T. O'Brien et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN
J. L. Whitwell et al.
NEUROLOGY (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
FUS Transgenic Rats Develop the Phenotypes of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
Cao Huang et al.
PLOS GENETICS (2011)
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
Ian R. A. Mackenzie et al.
ACTA NEUROPATHOLOGICA (2010)
Off-Label Medication Use in Frontotemporal Dementia
Bei Hu et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2010)
Accelerated Lipofuscinosis and Ubiquitination in Granulin Knockout Mice Suggest a Role for Progranulin in Successful Aging
Zeshan Ahmed et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Memantine Improves Cognition and Reduces Alzheimer's-Like Neuropathology in Transgenic Mice
Hilda Martinez-Coria et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia
Shigeki Hirano et al.
BRAIN (2010)
Caudate atrophy on MRI is a characteristic feature of FTLD-FUS
K. A. Josephs et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Galantamine for Alzheimer's disease
David Prvulovic et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia
Fangfang Yin et al.
FASEB JOURNAL (2010)
Fused in sarcoma/translocated in liposarcoma: A multifunctional DNA/RNA binding protein
Shu Yang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Effects of Cholinesterase Inhibitors on Visual Attention in Drivers With Alzheimer Disease
Lori A. Daiello et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration
Harro Seelaar et al.
JOURNAL OF NEUROLOGY (2010)
Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations
Ian R. A. Mackenzie et al.
ACTA NEUROPATHOLOGICA (2009)
An Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar Degeneration
Adam L. Boxer et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients
Steven Ferris et al.
ALZHEIMERS & DEMENTIA (2009)
FRONTOTEMPORAL DEMENTIAS: UPDATE ON RECENT DEVELOPMENTS IN MOLECULAR GENETICS AND NEUROPATHOLOGY
Rajka M. Liscic
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY (2009)
A new subtype of frontotemporal lobar degeneration with FUS pathology
Manuela Neumann et al.
BRAIN (2009)
Rethinking ALS: The FUS about TDP-43
Clotilde Lagier-Tourenne et al.
CELL (2009)
Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer's Disease
David Wilkinson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
Memantine Therapy of Behavioral Symptoms in Community-Dwelling Patients with Moderate to Severe Alzheimer's Disease
George T. Grossberg et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
The molecular basis of frontotemporal dementia
Manuela Neumann et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies
Patrizia Mecocci et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2009)
DUAL ACTION OF MEMANTINE IN ALZHEIMER DISEASE: A HYPOTHESIS
Tzong-Yuan Wu et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2009)
Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions
Keith A. Josephs et al.
ACTA NEUROPATHOLOGICA (2008)
Progranulin mutation causes frontotemporal dementia in the Swedish Karolinska family
Huei-Hsin Chiang et al.
ALZHEIMERS & DEMENTIA (2008)
VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: Review of a unique disorder
Virginia E. Kimonis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response
Mattias K. Andersson et al.
BMC CELL BIOLOGY (2008)
CHOLINESTERASE INHIBITORS AND MEMANTINE: BEST PRACTICES
Rachelle S. Doody
CNS SPECTRUMS (2008)
Galantamine in frontotemporal dementia and primary progressive aphasia
A. Kertesz et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Progranullin locus deletion in frontotemporal dementia
I. Gijselinck et al.
HUMAN MUTATION (2008)
A 6-month, open-label study of memantine in patients with frontotemporal dementia
Janine Diehl-Schmid et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation
Matthew J. Winton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structural determinants of the cellular localization and shuttling of TDP-43
Youhna M. Ayala et al.
JOURNAL OF CELL SCIENCE (2008)
TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor
I. -Fan Wang et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription
Xiangting Wang et al.
NATURE (2008)
Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series
Barbara Borroni et al.
NEUROGENETICS (2008)
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
Lars M. Ittner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro
Julie van der Zee et al.
HUMAN MOLECULAR GENETICS (2008)
The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments
Ian R. A. Mackenzie et al.
NEUROGENETICS (2007)
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia
Murray Grossman et al.
ARCHIVES OF NEUROLOGY (2007)
Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia
Simon M. Laws et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Frontotemporal dementia treatment: Current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies
Adam L. Boxer et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2007)
Clinicopathologic correlation in PGRN mutations
S. Davion et al.
NEUROLOGY (2007)
TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease
Linda K. Kwong et al.
ACTA NEUROPATHOLOGICA (2007)
Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy
Jake B. Guinto et al.
ACTA NEUROPATHOLOGICA (2007)
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration
Nigel J. Cairns et al.
ACTA NEUROPATHOLOGICA (2007)
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein
Michael J. Strong et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43
Yvonne Davidson et al.
ACTA NEUROPATHOLOGICA (2007)
Memantine for behavioral disturbances in frontotemporal dementia - A case series
Margaret M. Swanberg
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2007)
Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism
Andreas Fellgiebel et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2007)
Preliminary findings: Behavioral worsening on donepezil in patients with frontotemporal dementia
Mario F. Mendez et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Sarcomas: genetics, signalling, and cellular origins. Part I: The fellowship of TET
N. Riggi et al.
JOURNAL OF PATHOLOGY (2007)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts et al.
NATURE (2006)
In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias
V Di Lazzaro et al.
NEUROLOGY (2006)
A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia
ED Huey et al.
NEUROLOGY (2006)
TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines
R Fujii et al.
JOURNAL OF CELL SCIENCE (2005)
Clinical features of frontotemporal dementia
AL Boxer et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2005)
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
G Skibinski et al.
NATURE GENETICS (2005)
The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology
R Fujii et al.
CURRENT BIOLOGY (2005)
Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration
M Franceschi et al.
ANNALS OF NEUROLOGY (2005)
Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein
GDJ Watts et al.
NATURE GENETICS (2004)
Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial
JB Deakin et al.
PSYCHOPHARMACOLOGY (2004)
Rivastigmine in frontotemporal dementia - An open-label study
R Moretti et al.
DRUGS & AGING (2004)
Frontotemporal dementia: A randomised, controlled trial with trazodone
F Lebert et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)
Neurofilament inclusion body disease: a new proteinopathy?
KA Josephs et al.
BRAIN (2003)
A Canadian cohort study of cognitive impairment and related dementias (ACCORD): Study methods and baseline results
H Feldman et al.
NEUROEPIDEMIOLOGY (2003)
Epidemioloo and genetics of frontotemporal dementia/Pick's disease
T Bird et al.
ANNALS OF NEUROLOGY (2003)
Frontotemporal dementia: Paroxetine as a possible treatment of behavior symptoms - A randomized, controlled, open 14-month study
R Moretti et al.
EUROPEAN NEUROLOGY (2003)
Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration
YAL Pijnenburg et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Lipofuscin: Mechanisms of age-related accumulation and influence on cell function
UT Brunk et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
J Götz et al.
SCIENCE (2001)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
Share Paper
